Cannabis News
Psychedelics Show Promise As An ‘Entirely New Type Of Anti-Inflammatory Treatment,’ Research Suggests
“Evidence is growing in the key to managing inflammation of psychedelics, including a major driver of many chronic body diseases, depression, arthritis and heart conditions.”
Nicholas Barnes at the University of Birmingham, through dialogue
Once hippies and hallucination experiences are synonymously exploring psychedelic drugs today for their medical potential. The stigma of this era was eliminating drugs according to laws, however, moved with mental health treatments, scientists have returned to this discussed izer of medicine.
Psilocybin substances (found in magical mushrooms) and Ayahuasca are seriously taking scientists and doctors, they do not have caused perspectives, but if they have potential healing.
Initially, he focused on treating mental health conditions such as depression, which only helps the drugs prescribed today. But these studies have been expanded to internalize diseases driven by the inflammation, which can help reduce the immune system soothing.
Laboratory dishes and animal exams and animal exams, DMT, LSD can release inflammatory molecules called cytokines called cytokines. These protein molecules also rheumatoid arthritis, asthma as well as depression, in addition to increasing brain damage, after traumatic brain injury.
Advantage of steroids
But these drugs have a great advantage over the typical anti-infinite medications against steroids, because psychedelics work because it works without removing healthy immune function, which is the main problem with steroids.
Important, these lab findings are beginning to confirm in human studies. The evidence is growing the key to managing inflammation of psychedelics, including one of many chronic body diseases, including depression, arthritis and heart conditions.
Take the active ingredient in psilocybin, magic mushrooms. In a study with 60 healthy participants, only one dose was enough for two inflammatory molecule-tnf-alpha and IL-6-6-6 – next week.
However, not all studies show the same light results. Some people only had a few participants and others were complex because some participants had previous drug experience, which may affect results.
It is a great challenge to learn psychedelic in medicine research because it is very difficult to get real drugs and hide the placebo. When someone has a great psychedelic experience, it’s obvious that they didn’t take the sugar pill.
This challenges to interpret the results, especially aspects such as moods, which can significantly cause expectations. Changes in the body, too, can cause such inflammation, this placebo effect.
Meanwhile, the Amazonian Brew with the DMT psychedelic drug showed the promising results of people with hard depression and patients. In a study, those provided by Ayahuasca reduced the level of an inflammatory marker called CRP.
The higher the CRP drop, the greater the improvements in humor. This suggests that reducing inflammation can lead to improving mental health and conditions like depression and schizophrenia are related to inflammation of the body.
Scientists believe that psychedelic is especially true for 5-HT2A recipient, a part of the brain cells that usually responds to serotonin, called the “happy hormone”.
This recipient establishes a chain of chemical reactions within the cells. Here are the amazing parts: inflammatory effects against psychedelicism would not rely on the same processes that cause mind to change mind experiences, such as some calcium signals and other well-studied means. In fact, researchers believe that different mechanisms that are not understood can be involved, though yet invented.
In an analysis of the anxiety of asthma, there were two drugs with similar psychedelic effects, (R) -Do (R) -Dotfm, different results against anti-inflamity. The first drug was completely reversed swelling, and the other did nothing. This even more suggests that anti-inflammatory effects can be separated from psychedelic effects, opening the door to develop more safier medication.
The next generation of inflammatory anti-inflammatory pipi-psychedelic drug-psychedelic drugs come from I call. These are medications designed to imitate the therapeutic benefits of psychedelics, without causing hallucinations.
Several drugs have been identified, such as DLX-001 and DLX-159, Delix Therapeutics, developing the American Pharmaceutical Company. These experimental drugs show answers that represent antidepressive effects of “travel without affecting. Inflammation could be transformed into many conditions related to inflammation, without the reluctance of a regulatory complication or patient associated with psychedelic.
Although research in the early stages, evidence is being built in psychedelic or new drugs developed, can become a completely new type of inflammatory anti-inflammatory. People with long-term inflammatory diseases begin and use more stringent and innovative placebo-controlled designs, we can think of immersing the world in the world of psychedelism to be unexpected diseases.
The potential of the hallucinogenic effects flows treatment for many patients with the conditions that inflammation complies with the fundamental role.
This story first published the interview.
Photo elements courtesy CarlosemMaskypy and Apollo.
Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.
The medicinal cannabis sector is struggling to take root, and another specialist processing plant is set to close. But with current regulations and a new collective industry in mind, New Zealanders are promising to reduce their reliance on imported medicinals.
There was great excitement when medicinal cannabis was legalized and then regulated in 2020, with the hope of growing the domestic sector and serving patients here and abroad. However, since then, several companies have closed their doors, including Greenfern Industries, Cannasouth and, most recently, Helius Therapeutics.
The latter plans to close the East Tāmaki plant, affecting 65 workers. It is one of the few medicinal cannabis factories in the entire nation that has a specialized processing certificate called “Good Manufacturing Practice” (GMP).
Medical Cannabis Council executive director Sally King said that under current rules, most growers did not have such certification, and could only sell raw ingredients, not processed products such as more profitable cannabis capsules.
Read more at the town
Cannabis News
Medical Marijuana Helps People Stop Using Opioids, Sleeping Aids And Other Prescription Drugs, Study Shows
Using medical marijuana appears to help reduce the use of other medications, including opioids, sleep aids and antidepressants, according to a new study of more than 3,500 patients. They experience far fewer negative side effects after switching from prescription drugs to cannabis.
The survey results show that across all medication categories, patients were able to reduce their use of other prescription drugs by an average of 84.5 percent after starting to use medical cannabis.
More than half of the patients (58.9 percent) completely stopped using other prescription drugs.
The study, conducted and published by medical cannabis and telehealth company Bloomwell, conducted an online survey of 3,528 patients in Germany last month.
“Through the use of medical cannabis, patients were able to reduce their use of other prescription medications by an average of 84.5% across all categories.”
93.4 percent of patients taking sleeping pills were able to cut their use in half after starting medical marijuana, and 75.5 percent were able to get off the medication completely.
For methylphenidate, an ADHD drug sold under the name Ritalin, 77.3 percent of medical marijuana patients stopped completely.
61 percent of patients who were previously dependent on opioids were able to stop completely with the help of medical marijuana.
Stopping the use of prescription drugs led to a significant reduction in drug-related side effects, with 60.7 percent reporting no longer experiencing them.
“These patient reports demonstrate that in many cases, in addition to the treatment of the actual symptoms, one of the key reasons for an individual therapeutic trial with medical cannabis is the absence or reduction of medication-related side effects,” the study concluded.
“60.7% of patients reported no longer experiencing medication-related side effects from using medical cannabis.”
There were positive side effects, however, with 67.8 percent saying medical cannabis helped them concentrate better, 61.9 percent said it helped them foster more social relationships, and 53.9 percent experienced fewer sick days from work.
“The primary reason for prescribing medicinal cannabis, in addition to treating symptoms, is to reduce or avoid the side effects of other medications,” Julian Wichmann, Bloomwell’s founder and CEO, said in a press release. “For example, anyone who can completely stop opioids using medical cannabis has a good chance of going about their daily lives and working without side effects.”
“So we shouldn’t demand restrictions on access to medical cannabis, but rather make sure doctors are willing to do an individual therapeutic trial with medical cannabis, or at least recommend it and refer patients to their colleagues,” he said. “At the same time, our survey shows that we should finally discuss the great benefits of medical cannabis more openly, instead of only warning about the empirically unproven risks and discrediting the flower.”
This is not the first study to position medical cannabis as a safer alternative to opioids and other prescription drugs.
About One in three Americans who use CBD say they take it as an alternative or supplement to at least one medication—especially painful ones—according to a federally funded study published in February.
Also, a recent federally funded study, published by the American Medical Association (AMA), added further evidence Marijuana can be an effective substitute for opioids in the treatment of chronic pain.
Other studies published by the AMA have found legalizing marijuana for medical or recreational purposes “Significantly associated with reduced opioid use among patients diagnosed with cancer.”
A separate paper published in October also found that Legalizing medical marijuana “is associated with a significant reduction in opioid prescriptions.”
In August, however, Australian researchers published a study that shows this Marijuana can be an effective substitute for opioids in pain management treatment.
Another study published last year in the journal Drug and Alcohol Review found that daily drug users with chronic pain cannabis use was associated with greater likelihood of opioid cessation-Especially among men.
Other studies also found this legalizing medical cannabis appears to have significantly reduced payments to doctors from opioid manufacturers who specialize in pain, the authors found that “this reduction is a consequence of the availability of medical marijuana as a substitute” for prescription analgesics.
Other recent studies also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That research found a ‘consistent negative relationship’ between legalization and fatal overdoses, effects more pronounced in states that legalized cannabis earlier in the opioid crisis. The authors estimated that legalizing recreational marijuana “is associated with a decrease of 3.5 deaths per 100,000 people.”
“Our findings suggest that expanding access to recreational marijuana could help combat the opioid epidemic,” the report said. “Prior studies overwhelmingly indicate that marijuana (especially for medical use) can reduce opioid prescriptions, and we see it successfully reducing overdose deaths as well.”
Another recently published report on prescription opioid use in Utah follows the state legalizing medical marijuana found that the availability of legal cannabis reduced opioid use among chronic pain patients and helped reduce prescription drug overdose deaths across the state. Overall, the study’s results indicated that “cannabis plays a significant role in pain management and reducing opioid use,” he said.
President Donald Trump said in December that marijuana can “make people feel a lot better.” and serves as a “substitute for addictive and potentially deadly opioid painkillers.” issued an executive order to federally regulate cannabis and promote access to CBD for therapeutic purposes. He clarified, however, that he personally has no interest in using marijuana himself.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
United Food and Commercial Workers (UFCW) Local 360 has announced that more cannabis workers in New Jersey are joining its union family. Workers at Hamilton, New Jersey-based cannabis product manufacturer Sun Extractions chose to unionize with Local 360 for the better wages, benefits and benefits that come with a union contract.
Their decision adds to the growing momentum of UFCW Local 360’s Cannabis Workers Rising campaign, which has helped shape statewide labor standards and increase worker, consumer and community safety in New Jersey’s fledgling legal marijuana industry.
“New Jersey’s cannabis industry is stronger today thanks to this vote by Sun Extractions workers,” said Hugh Giordano, UFCW Local 360 Organizing Director. “Sustainable success for companies, workers and communities starts with fair treatment, strong standards and shared commitments. This is how jobs in the cannabis industry become long-term careers, and the future these workers work for.”
“It’s great that this vote is being announced before 4/20,” Giordano added. “4/20 used to be about the plant, but it has become a holiday that celebrates the entire cannabis community and recognizes the workers who grow, cut, pack, package, advise and distribute our cannabis products. Their hard work is why New Jersey’s medical and adult markets are safe and growing, and why sales are on target to exceed $2 billion this year.”
UFCW Local 360 President Sam Ferraino, Jr. emphasized that the Sun Extractions vote is part of a growing push to improve worker protections and benefits in the legal marijuana industry.
“We have more reasons than ever to celebrate 4/20 this year. We welcome the employees of Sun Extractions to the Local 360 family, seeing the hard work of our members move an entire industry forward, and speaking to other states, looking to New Jersey as a model of how to do it,” said Ferraino. “It’s further proof of what we always say: stronger unions mean stronger industries and communities. And that’s worth celebrating.”
For more than a decade, UFCW Local 360 has been at the forefront of efforts to ensure that New Jersey’s cannabis industry offers fair wages, strong job protections and real advancement opportunities. Thousands of cannabis workers, from cultivation to retail, have joined the union since the Cannabis Workers Rising campaign began.
From seed to sale, UFCW is the national leader in organizing workers in the cannabis industry and is the official cannabis union of the AFL-CIO. In the US, UFCW works with workers and business owners to achieve the shared goal of a regulated cannabis industry that provides family-supporting jobs and promotes social equity.
For more information:
UFCW
www.ufcw.org
Freshwater Biscotti Marijuana Monday
Cornbread Hemp CEO Jim Higdon Calls for Regulations Before Ron Wyden’s Files his Bill in Senate
The Dark Secret Of Legal Cannabis
INHALE MD | DR JORDAN TISHLER [cannabis best practices]
Marijuana Retail Report
Aurora Cannabis Acquires Cultivator for C$26.5 Million – New Cannabis Ventures
Nascent medical cannabis industry aims for growth
Medical Marijuana Helps People Stop Using Opioids, Sleeping Aids And Other Prescription Drugs, Study Shows
Report: Pre-Rolls Become Largest Cannabis Industry Product Category
Black Scissor Hash Wednesday
“Our system can manage equipment across 10,000+ m² using just a few wires”
Florida Workshop to Discuss What Constitutes a ‘Cartoon’ in Hemp Packaging
Mazar-i-Sharif Hash Wednesday
From Finance to Wellness: Brad Zerman’s Impactful Pivot
Re-release of the full show of Cannabis Coast to Coast news. Republican Texas DA Fires Up vs. laws;
DEA’s Cole Reverses His “priorities” ; Prohibitionists Dig In; Dead & Co Celebrates 60 years in SF
Weak Michigan Cannabis Sales Again in July – New Cannabis Ventures
Your Cannabis Business: Consistent Filings Are Critical
New Hampshire Governor Says Federal Marijuana Rescheduling Won’t Change Her Opposition To Legalization
Texas DA Fires Up for Change! Mass. Sheriff arrested on Extortion charges; GOP vs Industry in state
-
Cannabis News8 months ago“Our system can manage equipment across 10,000+ m² using just a few wires”
-
Florida8 months agoFlorida Workshop to Discuss What Constitutes a ‘Cartoon’ in Hemp Packaging
-
Video7 months agoMazar-i-Sharif Hash Wednesday
-
Video8 months agoFrom Finance to Wellness: Brad Zerman’s Impactful Pivot
-
Video8 months agoRe-release of the full show of Cannabis Coast to Coast news. Republican Texas DA Fires Up vs. laws;
-
Video8 months agoDEA’s Cole Reverses His “priorities” ; Prohibitionists Dig In; Dead & Co Celebrates 60 years in SF
-
aawh8 months agoWeak Michigan Cannabis Sales Again in July – New Cannabis Ventures
-
Best Practices8 months agoYour Cannabis Business: Consistent Filings Are Critical